Allen W. Zhang

2775 Laurel Street
10127
Vancouver, BC V5Z1M9, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Correction: Ormiston et al. Estrogen Signaling During Abrupt Involution and Long-Term Metabolic Signature Similar to Estrogen Receptor-Negative Breast Cancer. Int. J. Mol. Sci. 2026, 27, 1951.

Correction: Ormiston et al. Estrogen Signaling During Abrupt Involution and Long-Term Metabolic Signature Similar to Estrogen Receptor-Negative Breast Cancer. Int. J. Mol. Sci. 2026, 27, 1951.

Journal: International journal of molecular sciences

Published: August 14, 2026

Unusual morphologic features in molecularly defined high-grade sarcomas of the uterus.

Unusual morphologic features in molecularly defined high-grade sarcomas of the uterus.

Journal: Annals of diagnostic pathology

Published: May 09, 2026

NTRK-rearranged uterine sarcomas with heterologous rhabdomyoblastic and cartilaginous differentiation: expanding the morphological spectrum with discussion of passenger NTRK molecular events.

NTRK-rearranged uterine sarcomas with heterologous rhabdomyoblastic and cartilaginous differentiation: expanding the morphological spectrum with discussion of passenger NTRK molecular events.

Journal: Virchows Archiv : an international journal of pathology

Published: March 30, 2026

Recommendations for Pathologist-Led Deployment of Artificial Intelligence Tools as Laboratory-Developed Tests.

Recommendations for Pathologist-Led Deployment of Artificial Intelligence Tools as Laboratory-Developed Tests.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: February 10, 2026

Estrogen Signaling During Abrupt Involution and Long-Term Metabolic Signature Similar to Estrogen Receptor-Negative Breast Cancer.

Estrogen Signaling During Abrupt Involution and Long-Term Metabolic Signature Similar to Estrogen Receptor-Negative Breast Cancer.

Journal: International journal of molecular sciences

Published: January 13, 2026

Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinement.

Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinement.

Journal: Gynecologic oncology

Published: November 26, 2025

Estrogen Signaling During Abrupt Involution Leads to Long-Term Metabolic Dysfunction Similar to Estrogen Receptor Negative Breast Cancer.

Estrogen Signaling During Abrupt Involution Leads to Long-Term Metabolic Dysfunction Similar to Estrogen Receptor Negative Breast Cancer.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma Is Associated With Poor Clinical Outcomes in a Canadian Cohort.

Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma Is Associated With Poor Clinical Outcomes in a Canadian Cohort.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: September 09, 2025

Cross-Platform Methylation-Based Site of Origin Classification for Squamous Cell Carcinomas.

Cross-Platform Methylation-Based Site of Origin Classification for Squamous Cell Carcinomas.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: February 19, 2025

Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinoma.

Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinoma.

Journal: The Journal of pathology

Published: October 18, 2024

Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancer.

Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancer.

Journal: bioRxiv : the preprint server for biology

Published: July 29, 2024

Ongoing genome doubling shapes evolvability and immunity in ovarian cancer.

Ongoing genome doubling shapes evolvability and immunity in ovarian cancer.

Journal: Nature

Published: July 11, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026